癌抗原CA19-9 是胰(yi)腺癌(ai)(ai),胃癌(ai)(ai),結腸癌(ai)(ai)、直腸癌(ai)(ai)、膽囊癌(ai)(ai)的(de)相關標志物,大量(liang)研究證明(ming)CA19-9濃度與這些腫(zhong)瘤大小有關(guan),是(shi)至今報道的對(dui)胰腺癌敏(min)感性最高的標志物。
CA19-9癌抗原(yuan)19-9 | 貨號 |
CA19-9 Cancer Antigen, Specification> 100 Ku/ml | P291-4 |
Cancer Antigen 19-9 (CA 19-9) Antigen, Native | LA055 |
Cancer Antigen 19-9 (CA 19-9) Antigen, Native,應(ying)用:Control | LA316 |
Cancer Antigen 19-9 (CA 19-9),Highly Purified,Liquid | 151-99 |
CA 19-9 (low cross reactivity), Partially Purified | CT 3286 |
CA 19-9 (low cross reactivity), Part Purified | AU 3264 |
CA 19-9, Grade II (low cross reactivities), Part Purified | AU 3302 |
CA 19-9, Highly Purified | AU 3220 |
CA 19-9, Highly Purified | CT 3287 |
希凱生物是BBI Solutions、Medix Biochemica、Lee BioSolutions、Eastcoast Bio、Diaclone、Aalto Bio授權代理商
提(ti)供高(gao)品質(zhi)診斷試(shi)劑原料,更(geng)多產品信息,歡迎與我(wo)們聯系(xi)